carbon monoxide has been researched along with cyclosporine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| El-Mas, MM; Helmy, MM; Mohy El-Din, MM; Omar, AG | 1 |
| El-Gowelli, HM; El-Mas, MM; El-Yazbi, AF; Ibrahim, KS | 1 |
| Cui, Y; Fang, J; Guo, C; Hu, W; Song, B; Xia, M; Xia, Z; Xu, D; Xue, Y; Zhang, C; Zhang, S | 1 |
3 other study(ies) available for carbon monoxide and cyclosporine
| Article | Year |
|---|---|
Crosstalk between central pathways of nitric oxide and carbon monoxide in the hypertensive action of cyclosporine.
Topics: Animals; Carbon Monoxide; Cyclosporine; Guanylate Cyclase; Heart Rate; Heme Oxygenase (Decyclizing); Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Signal Transduction | 2012 |
Heme oxygenase byproducts variably influences myocardial and autonomic dysfunctions induced by the cyclosporine/diclofenac regimen in female rats.
Topics: Animals; Autonomic Nervous System; Baroreflex; Carbon Monoxide; Cyclosporine; Diclofenac; Female; Heart Rate; Heart Ventricles; Heme Oxygenase (Decyclizing); Hemodynamics; Myocardium; Rats, Wistar | 2018 |
Nanoformulation of a carbon monoxide releasing molecule protects against cyclosporin A-induced nephrotoxicity and renal fibrosis via the suppression of the NLRP3 inflammasome mediated TGF-β/Smad pathway.
Topics: Animals; Anti-Inflammatory Agents; Carbon Monoxide; Cyclosporine; Fibrosis; Humans; Inflammasomes; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Transforming Growth Factor beta | 2022 |